Fidelity Select Medical Delivery Portfolio

Class No Load (FSHCX)
Scorecard
3 / 5 Stars
Lipper
3 1 4 4 3
Zacks Investment Research
1 (Strong Buy)
Standard & Poor's
3 / 5 Stars
TheStreet.com
C (Hold)

#21 in Health

U.S. News evaluated 38 Health Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.

See all Fidelity Investments funds

See full Health rankings

See more fund rankings

Performance

The fund has returned 7.65 percent over the past year, 14.09 percent over the past three years, 10.31 percent over the past five years, and 14.45 percent over the past decade.

Trailing Returns Updated 04.30.2013
Year to date 9.7%
1 Year 7.6%
3 Years (Annualized) 14.1%
5 Years (Annualized) 10.3%
10 Years (Annualized) 14.5%

See more FSHCX performance

Summary

The investment seeks capital appreciation. The fund normally invests at least 80% of assets in securities of companies principally engaged in the ownership or management of hospitals, nursing homes, health maintenance organizations, and other companies specializing in the delivery of health care services. It invests primarily in common stocks. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified.

Fees

Fees are Low compared to funds in the same category.
Fidelity Select Medical Delivery Portfolio has an expense ratio of 0.83 percent.

See more FSHCX fees

Risk

Risk is High compared to funds in the same category according to Morningstar.

See more FSHCX risk

Advertisement
Healths
Rankings

See More Funds

Highest Returns (10-year)

See More Funds

Slide Shows
7 Mutual Funds That Make Huge Bets

These funds invest much of their portfolios in one company.

Why Dow 14,000 Is a Tough Milestone

History shows this mark to be one of the most difficult for the market.

Emerging Markets to Consider in 2013

The Philippines, China and other key emerging markets for this year.